- Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
-
Rashid M, Oldham E, Hughes GK, Peña AM, Ladd C, Gardner B, McIntire R, Johnson B, Tuia J, Haslam A, Prasad V, Vassar M
- KMID: 2561833
- J Urol Oncol.
- 2024 Nov;22(3):211-223.
- doi: 10.22465/juo.244800520026
Purpose: Our study aimed to evaluate the risk and benefit profiles of clinical trials using abiraterone in cancer treatment. Materials and Methods: A comprehensive search was conducted on May 24, 2023,... -
- CITED
-
- Close
- SHARE
-
- Close
- Interpretation of androgen and anti-Mullerian hormone profiles in a Hispanic cohort of 5- to 8-year-old girls with premature adrenarche
-
Brar PC, Dingle E, Ovadia D, Pivo S, Prasad V, David R
- KMID: 2432283
- Ann Pediatr Endocrinol Metab.
- 2018 Dec;23(4):210-214.
- doi: 10.6065/apem.2018.23.4.210
PURPOSE: Premature adrenarche (PA) often leads to polycystic ovary syndrome (PCOS). Higher anti-mullerian hormone (AMH) levels are reported in PCOS. We studied the androgen profile and AMH profiles in Hispanic... -
- CITED
-
- Close
- SHARE
-
- Close
